These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11395899)

  • 1. Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy.
    Davenport A
    Contrib Nephrol; 2001; (132):313-22. PubMed ID: 11395899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study.
    Aman J; Nurmohamed SA; Vervloet MG; Groeneveld AB
    J Crit Care; 2010 Mar; 25(1):120-7. PubMed ID: 19427760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
    Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
    Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do bicarbonate-based solutions for continuous renal replacement therapy offer better control of metabolic acidosis than lactate-containing fluids?
    Agarwal B; Kovari F; Saha R; Shaw S; Davenport A
    Nephron Clin Pract; 2011; 118(4):c392-8. PubMed ID: 21346374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which bicarbonate concentration is adequate to lactate-buffered substitution fluids in maintenance hemofiltration?
    Böhm R; Gladziwa U; Clasen W; Riehl J; Mann H; Sieberth HG
    Clin Nephrol; 1994 Oct; 42(4):257-62. PubMed ID: 7834919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit--the role of renal replacement therapy.
    Naka T; Bellomo R
    Crit Care; 2004 Apr; 8(2):108-14. PubMed ID: 15025771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous renal replacement therapy].
    Knotek M; Prkacin I; Skegro D; Sabljar-Matovinović M
    Lijec Vjesn; 2001; 123(9-10):255-8. PubMed ID: 11845582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous renal replacement therapy: cause and treatment of electrolyte complications.
    Fall P; Szerlip HM
    Semin Dial; 2010; 23(6):581-5. PubMed ID: 21166876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrolyte disorders and substitution fluid in continuous renal replacement therapy.
    Locatelli F; Pontoriero G; Di Filippo S
    Kidney Int Suppl; 1998 May; 66():S151-5. PubMed ID: 9573593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units.
    Brause M; Neumann A; Schumacher T; Grabensee B; Heering P
    Crit Care Med; 2003 Mar; 31(3):841-6. PubMed ID: 12626994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bicarbonate instead of lactate buffered substitution solution for continuous hemofiltration in intensive care].
    Olbricht CJ; Huxmann-Nägeli D; Bischoff H
    Anasth Intensivther Notfallmed; 1990 Apr; 25(2):164-7. PubMed ID: 2360710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure.
    Davenport A
    Int J Artif Organs; 2008 Jan; 31(1):3-5. PubMed ID: 18286449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy.
    Tillman J
    Nurs Crit Care; 2009; 14(4):191-9. PubMed ID: 19531037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous renal replacement therapies (CRRT)].
    Canepari G; Inguaggiato P; Gigliola G; Bainotti S; Formica M
    G Ital Nefrol; 2006; 23 Suppl 36():S30-7. PubMed ID: 17068727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysate and replacement fluid composition for CRRT.
    Aucella F; Di Paolo S; Gesualdo L
    Contrib Nephrol; 2007; 156():287-96. PubMed ID: 17464138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.